Canopy Growth (CGC)
(Delayed Data from NSDQ)
$4.41 USD
-0.41 (-8.51%)
Updated Oct 1, 2024 04:00 PM ET
Pre-Market: $4.41 0.00 (0.00%) 9:14 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.41 USD
-0.41 (-8.51%)
Updated Oct 1, 2024 04:00 PM ET
Pre-Market: $4.41 0.00 (0.00%) 9:14 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Zacks News
Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $18.60, moving +0.59% from the previous trading session.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $16.47 in the latest trading session, marking a -1.32% move from the prior day.
Canopy Growth Corporation (CGC) Stock Moves -0.22%: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $18.11, marking a -0.22% move from the previous day.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $16.02 in the latest trading session, marking a -1.9% move from the prior day.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $16.47, moving +1.92% from the previous trading session.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $16.59, moving -0.72% from the previous trading session.
Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba
by Zacks Equity Research
Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba
Is This a Buying Opportunity in the Marijuana Stocks?
by Tracey Ryniec
The marijuana stocks plunged during the coronavirus sell-off. Should investors be taking a second look?
Is the Options Market Predicting a Spike in Canopy Growth (CGC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $17.18, moving +1.72% from the previous trading session.
Is it Time to Buy Cannabis Stocks & ETFs?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Canopy Growth Corporation (CGC) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -286.67% and -14.99%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Canopy Growth (CGC) This Earnings Season?
by Zacks Equity Research
Canopy Growth (CGC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Canopy Growth (CGC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal fourth quarter.
Canopy Growth (CGC) in Focus: Stock Moves 6.4% Higher
by Zacks Equity Research
Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Will Ventilator Sales Drive Medtronic's (MDT) Q4 Earnings?
by Zacks Equity Research
Medtronic (MDT) might have registered lower demand for its emergency procedures in Q4 with patients trying to avoid any non-COVID-19 emergency treatment.
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions and Medical-Surgical Solutions segments.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $15.08, marking a -1.71% move from the previous day.
Are Marijuana Stocks, ETFs Poised for Upbeat Earnings?
by Sanghamitra Saha
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $15.76, marking a +0.13% move from the previous day.
Constellation Brands (STZ) Tops Q4 Earnings & Sales Estimates
by Zacks Equity Research
Constellation Brands (STZ) reports strong fourth-quarter fiscal 2020 results, driven by continued strength in the beer business and gains in the wine & spirits segment.
The Zacks Analyst Blog Highlights: UBER, ZM, MSFT, STZ and CGC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UBER, ZM, MSFT, STZ and CGC
Booze Takes The Edge Off The Coronavirus
by Daniel Laboe
Alcohol sales are flying this month and online delivery services are a primary catalyst
Buy Corona Maker Constellation (STZ) Stock Before Q4 Earnings Amid Surge?
by Benjamin Rains
Constellation Brands (STZ) shares have surged 40% in the last week. So now might be time for investors to consider buying the Corona beer maker's stock before it reports its Q4 fiscal 2020 results on Friday, April 3...
Are Marijuana Stocks & ETFs Coronavirus-Proof?
by Sanghamitra Saha
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?